Benchmark Reiterates Buy on CSG Systems Intl, Maintains $73 Price Target
Benchmark analyst Matthew Harrigan reiterates CSG Systems Intl (NASDAQ:CSGS) with a Buy and maintains $73 price target.
Oppenheimer Initiates Coverage On CSG Systems Intl with Outperform Rating, Announces Price Target of $75
Oppenheimer analyst Timothy Horan initiates coverage on CSG Systems Intl (NASDAQ:CSGS) with a Outperform rating and announces Price Target of $75.
Benchmark Initiates Coverage On CSG Systems Intl with Buy Rating, Announces Price Target of $73
Benchmark analyst Matthew Harrigan initiates coverage on CSG Systems Intl (NASDAQ:CSGS) with a Buy rating and announces Price Target of $73.
Clorox, Crocs And Some Other Big Stocks Moving Lower On Thursday
AMTD Digital Inc. (NYSE: HKD) dipped 43.6% to $620.00 on possible profit taking after the stock surged over the last few trading days.
Recap: CSG Systems Intl Q2 Earnings
CSG Systems Intl (NASDAQ:CSGS) reported its Q2 earnings results on Wednesday, August 3, 2022 at 04:05 PM.
Here's what investors need to know about the announcement.
Earnings
CSG Systems Intl reported in-line EPS of $0.84 versus an estimate of $0.84.
CSG Systems Intl: Q1 Earnings Insights
CSG Systems Intl (NASDAQ:CSGS) reported its Q1 earnings results on Wednesday, May 4, 2022 at 04:05 PM.
Here's what investors need to know about the announcement.
Earnings
CSG Systems Intl beat estimated earnings by 8.86%, reporting an EPS of $0.86 versus an estimate of $0.79.
Earnings Scheduled For May 4, 2022
Companies Reporting Before The Bell
• Seres Therapeutics (NASDAQ:MCRB) is estimated to report quarterly loss at $0.52 per share on revenue of $8.48 million.